Global Ciprofloxacin HCL Market Size, Share, and Trends Analysis Report, By Application (Urogenital Infections, Respiratory Tract Infections, Gastrointestinal Infections, Typhoid, Bone & Joint Infections, Skin & Soft Tissue Infections, Sepsis and Other Systemic Infections), Forecast (2022-2028)

The global ciprofloxacin HCL market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The global ciprofloxacin HCL market is growing due to the increased prevalence of different types of infectious diseases globally.  The rising prevalence of pneumonia cases globally is also boosting the market growth. According to World Health Organization (WHO), around 14% of all deaths of children under 5 years old, which accounts for 740,180 children in 2019 died due to pneumonia. The rising prevalence of typhoid cases globally is also boosting the growth of the ciprofloxacin HCL market. According to the article published by WHO in January 2018, around 11–20 million people get sick from typhoid, and between 128,000 and 161,000 people die from it every year. The rising awareness among individuals about the different types of infectious diseases and the treatments available to cure them is also boosting the growth of the global ciprofloxacin HCL market. Additionally, improved healthcare infrastructure along with investment in research and development for the advancement in treatment is also boosting the growth of the global ciprofloxacin HCL market in the forecast period.

 

The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new launches, to stay competitive in the market. For instance-

 

• In August 2020, Dr. Reddy’s Laboratories Ltd. announced the launch of Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, a therapeutic equivalent generic version of Ciprodex.
• In August 2020, Sandoz AG announced the launch of Ciprofloxacin + Dexamethasone otic suspension in the US for the treatment of middle and outer ear bacterial infections.

 

Market Coverage

• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., WOCKHARDT, and Taro Pharmaceutical Industries Ltd. among others.

 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global Ciprofloxacin HCL Market Report by Segment

By Application

• Urogenital Infections
• Respiratory Tract Infections
• Gastrointestinal Infections
• Typhoid
• Bone & Joint Infections
• Skin & Soft Tissue Infections
• Sepsis
• Other Systemic Infections

 

Global Ciprofloxacin HCL Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa